Latest Administration News

TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

QGold Pty Ltd has initiated an unconditional on-market takeover offer for all shares in Venus Metals Corporation Limited at a 21% premium, aiming to consolidate control and potentially delist the explorer.

QGold Pty Ltd has launched an unconditional on-market takeover offer for all shares of Venus Metals Corporation Limited at a 21% premium, providing shareholders with immediate cash liquidity. The offer, backed by a substantial funding arrangement, signals potential strategic shifts for Venus Metals.

Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

Redivium Limited has advanced its battery recycling ambitions with a binding offtake agreement alongside strategic funding plans, despite ongoing ASX suspension. The company’s new partnership with WMC Energy BV marks a pivotal step toward commercialising its UK recycling facility.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

HUB24 Limited showcased strong growth and strategic innovation at its 2025 Investor Strategy Day, highlighting market leadership and ambitious expansion plans across wealth management technology.

Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.

Havilah Resources has secured a binding term sheet with Sandfire Resources for a potential $210 million earn-in at Kalkaroo, while reporting high-grade uranium results and raising $2 million in a share placement.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.